GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DHG Pharmaceutical JSC (STC:DHG) » Definitions » EV-to-Revenue

DHG Pharmaceutical JSC (STC:DHG) EV-to-Revenue : 2.61 (As of May. 05, 2024)


View and export this data going back to 2006. Start your Free Trial

What is DHG Pharmaceutical JSC EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, DHG Pharmaceutical JSC's enterprise value is ₫13,087,710 Mil. DHG Pharmaceutical JSC's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₫5,015,395 Mil. Therefore, DHG Pharmaceutical JSC's EV-to-Revenue for today is 2.61.

The historical rank and industry rank for DHG Pharmaceutical JSC's EV-to-Revenue or its related term are showing as below:

STC:DHG' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.19   Med: 2.54   Max: 4.23
Current: 2.61

During the past 13 years, the highest EV-to-Revenue of DHG Pharmaceutical JSC was 4.23. The lowest was 1.19. And the median was 2.54.

STC:DHG's EV-to-Revenue is ranked worse than
53.71% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs STC:DHG: 2.61

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), DHG Pharmaceutical JSC's stock price is ₫113500.00. DHG Pharmaceutical JSC's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₫38,080.34. Therefore, DHG Pharmaceutical JSC's PS Ratio for today is 2.98.


DHG Pharmaceutical JSC EV-to-Revenue Historical Data

The historical data trend for DHG Pharmaceutical JSC's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DHG Pharmaceutical JSC EV-to-Revenue Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.67 3.11 3.21 1.89 2.36

DHG Pharmaceutical JSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 2.04 3.09 2.85 2.36

Competitive Comparison of DHG Pharmaceutical JSC's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DHG Pharmaceutical JSC's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where DHG Pharmaceutical JSC's EV-to-Revenue falls into.



DHG Pharmaceutical JSC EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

DHG Pharmaceutical JSC's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13087709.580/5015395.04
=2.61

DHG Pharmaceutical JSC's current Enterprise Value is ₫13,087,710 Mil.
DHG Pharmaceutical JSC's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫5,015,395 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DHG Pharmaceutical JSC  (STC:DHG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

DHG Pharmaceutical JSC's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=113500.00/38080.341
=2.98

DHG Pharmaceutical JSC's share price for today is ₫113500.00.
DHG Pharmaceutical JSC's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫38,080.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DHG Pharmaceutical JSC EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of DHG Pharmaceutical JSC's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


DHG Pharmaceutical JSC (STC:DHG) Business Description

Traded in Other Exchanges
N/A
Address
288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic and antipyretic; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.

DHG Pharmaceutical JSC (STC:DHG) Headlines